US Stock MarketDetailed Quotes

APVO Aptevo Therapeutics

Watchlist
  • 3.030
  • -0.060-1.94%
Trading Mar 4 11:52 ET
4.42MMarket Cap-0.03P/E (TTM)

Aptevo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-14.81%24.6M
-0.03%6.38M
-20.55%5.21M
-26.34%6.02M
-9.97%6.98M
-9.06%28.88M
-16.92%6.38M
-15.71%6.56M
8.15%8.18M
-11.11%7.76M
Selling and administrative expenses
-13.14%10.22M
-10.42%2.5M
-21.09%2.11M
-12.33%2.38M
-9.95%3.23M
-15.15%11.77M
-7.21%2.79M
-19.14%2.67M
-26.54%2.72M
-7.02%3.59M
-General and administrative expense
-13.14%10.22M
-10.42%2.5M
-21.09%2.11M
-12.33%2.38M
-9.95%3.23M
-15.15%11.77M
-7.21%2.79M
-19.14%2.67M
-26.54%2.72M
-7.02%3.59M
Research and development costs
-15.95%14.38M
8.05%3.88M
-20.17%3.1M
-33.30%3.64M
-9.98%3.75M
-4.33%17.11M
-23.17%3.59M
-13.18%3.89M
41.32%5.46M
-14.34%4.17M
Operating profit
14.81%-24.6M
0.03%-6.38M
20.55%-5.21M
26.34%-6.02M
9.97%-6.98M
-0.83%-28.88M
16.92%-6.38M
15.71%-6.56M
-8.15%-8.18M
-38.23%-7.76M
Net non-operating interest income expense
Other net income (expense)
-95.39%472K
-62.77%70K
-50.66%112K
-38.70%141K
-98.45%149K
-71.31%10.23M
-92.54%188K
1,008.00%227K
-99.35%230K
523.28%9.58M
Special income (charges)
--0
--0
--0
--0
--0
--9.65M
--0
--0
--0
--9.65M
-Gain on sale of property,plant,equipment
--0
--0
--0
--0
--0
--9.65M
--0
--0
--0
--9.65M
Other non- operating income (expenses)
-18.34%472K
-62.77%70K
-50.66%112K
-38.70%141K
322.39%149K
-98.38%578K
-92.54%188K
1,008.00%227K
113.08%230K
97.04%-67K
Income before tax
-29.38%-24.13M
-1.87%-6.31M
19.47%-5.1M
25.98%-5.88M
-474.06%-6.83M
-365.90%-18.65M
-20.01%-6.2M
18.89%-6.33M
-128.53%-7.95M
123.20%1.83M
Income tax
Net income
-38.59%-24.13M
-6.93%-6.31M
19.47%-5.1M
25.98%-5.88M
-346.45%-6.83M
-316.91%-17.41M
-27.17%-5.9M
17.14%-6.33M
-128.38%-7.95M
136.03%2.77M
Net income continuous Operations
-29.38%-24.13M
-1.87%-6.31M
19.47%-5.1M
25.98%-5.88M
-474.06%-6.83M
-365.90%-18.65M
-20.01%-6.2M
18.89%-6.33M
-128.53%-7.95M
123.20%1.83M
Net income discontinuous operations
--0
--0
--0
--0
--0
22.31%1.24M
-43.76%293K
--0
--0
431.46%946K
Minority interest income
Net income attributable to the parent company
-38.59%-24.13M
-6.93%-6.31M
19.47%-5.1M
25.98%-5.88M
-346.45%-6.83M
-316.91%-17.41M
-27.17%-5.9M
17.14%-6.33M
-128.38%-7.95M
136.03%2.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.59%-24.13M
-6.93%-6.31M
19.47%-5.1M
25.98%-5.88M
-346.45%-6.83M
-316.91%-17.41M
-27.17%-5.9M
17.14%-6.33M
-128.38%-7.95M
136.03%2.77M
Basic earnings per share
96.23%-87.38
99.12%-4.3279
97.83%-17.76
-36.20%-2.72K
-157.25%-368.15
-190.64%-2.32K
68.08%-493.6444
66.42%-819.92
-121.97%-2K
125.48%643.06
Diluted earnings per share
96.23%-87.38
99.12%-4.3279
97.83%-17.76
-36.20%-2.72K
-157.25%-368.15
-190.64%-2.32K
68.08%-493.6444
66.42%-819.92
-121.97%-2K
125.48%643.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -14.81%24.6M-0.03%6.38M-20.55%5.21M-26.34%6.02M-9.97%6.98M-9.06%28.88M-16.92%6.38M-15.71%6.56M8.15%8.18M-11.11%7.76M
Selling and administrative expenses -13.14%10.22M-10.42%2.5M-21.09%2.11M-12.33%2.38M-9.95%3.23M-15.15%11.77M-7.21%2.79M-19.14%2.67M-26.54%2.72M-7.02%3.59M
-General and administrative expense -13.14%10.22M-10.42%2.5M-21.09%2.11M-12.33%2.38M-9.95%3.23M-15.15%11.77M-7.21%2.79M-19.14%2.67M-26.54%2.72M-7.02%3.59M
Research and development costs -15.95%14.38M8.05%3.88M-20.17%3.1M-33.30%3.64M-9.98%3.75M-4.33%17.11M-23.17%3.59M-13.18%3.89M41.32%5.46M-14.34%4.17M
Operating profit 14.81%-24.6M0.03%-6.38M20.55%-5.21M26.34%-6.02M9.97%-6.98M-0.83%-28.88M16.92%-6.38M15.71%-6.56M-8.15%-8.18M-38.23%-7.76M
Net non-operating interest income expense
Other net income (expense) -95.39%472K-62.77%70K-50.66%112K-38.70%141K-98.45%149K-71.31%10.23M-92.54%188K1,008.00%227K-99.35%230K523.28%9.58M
Special income (charges) --0--0--0--0--0--9.65M--0--0--0--9.65M
-Gain on sale of property,plant,equipment --0--0--0--0--0--9.65M--0--0--0--9.65M
Other non- operating income (expenses) -18.34%472K-62.77%70K-50.66%112K-38.70%141K322.39%149K-98.38%578K-92.54%188K1,008.00%227K113.08%230K97.04%-67K
Income before tax -29.38%-24.13M-1.87%-6.31M19.47%-5.1M25.98%-5.88M-474.06%-6.83M-365.90%-18.65M-20.01%-6.2M18.89%-6.33M-128.53%-7.95M123.20%1.83M
Income tax
Net income -38.59%-24.13M-6.93%-6.31M19.47%-5.1M25.98%-5.88M-346.45%-6.83M-316.91%-17.41M-27.17%-5.9M17.14%-6.33M-128.38%-7.95M136.03%2.77M
Net income continuous Operations -29.38%-24.13M-1.87%-6.31M19.47%-5.1M25.98%-5.88M-474.06%-6.83M-365.90%-18.65M-20.01%-6.2M18.89%-6.33M-128.53%-7.95M123.20%1.83M
Net income discontinuous operations --0--0--0--0--022.31%1.24M-43.76%293K--0--0431.46%946K
Minority interest income
Net income attributable to the parent company -38.59%-24.13M-6.93%-6.31M19.47%-5.1M25.98%-5.88M-346.45%-6.83M-316.91%-17.41M-27.17%-5.9M17.14%-6.33M-128.38%-7.95M136.03%2.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.59%-24.13M-6.93%-6.31M19.47%-5.1M25.98%-5.88M-346.45%-6.83M-316.91%-17.41M-27.17%-5.9M17.14%-6.33M-128.38%-7.95M136.03%2.77M
Basic earnings per share 96.23%-87.3899.12%-4.327997.83%-17.76-36.20%-2.72K-157.25%-368.15-190.64%-2.32K68.08%-493.644466.42%-819.92-121.97%-2K125.48%643.06
Diluted earnings per share 96.23%-87.3899.12%-4.327997.83%-17.76-36.20%-2.72K-157.25%-368.15-190.64%-2.32K68.08%-493.644466.42%-819.92-121.97%-2K125.48%643.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+2.30%
Alphabet-C
GOOG
+2.32%
Alphabet-A
GOOGL
+2.26%
NVIDIA
NVDA
+1.59%
MARA Holdings
MARA
+1.27%

Unlock the Full List